The Design and Application of Inhibiting Peptide for Rapid <em>In vitro</em> Downregulation of Post-Translational Modifications Levels at a Specific Site
Shuping Zhang, Xiaolin Gu(Cancer Hospital of Chinese Academy of Medical Sciences), Dong Zhang(Fudan University), Jiaqi Liu(Harbin Medical University), Ning Su(Nanjing Medical University), Zhixia Yang(Mudanjiang Medical University), Jie Yang
Cited by 1
Related Papers
Abraxas and RAP80 Form a BRCA1 Protein Complex Required for the DNA Damage Response
|Science|2007|696
The ubiquitin-specific protease USP28 is required for MYC stability
|Nature Cell Biology|2007|491
Cannabidiol (CBD) as a Promising Anti-Cancer Drug
|Cancers|2020|255